Ann: First CannEpil Product arrives in Australia, page-2

• In a significant milestone event for the Company, the first shipment of CannEpil™was officially exported from Slovenia on Friday to arrive in Australia today, Monday24 December

• All Australian import authorisations are in place to allow immediate transport to asecure facility at St Vincent’s Hospital, Melbourne

• CannEpilTM is available for supply through Authorised Prescribers, endorsed by theHuman Research Ethics Committee at St Vincent’s Hospital

• CannEpilTM is a Cannabinoids based IMP Phytomedicine developed by MXC

• Some Australian medical practitioners have already been granted approval asAuthorised Prescribers of CannEpilTM

• MXC and specialist pharmaceutical distributor, HL Pharma, are now able to arrangethe supply of CannEpilTM for patients who have been prescribed the product by anAuthorised Prescriber